IRLAB Therapeutics AB (publ) announced that at its Annual General Meeting held on may 11, 2022, An van Es-Johansson and Catharina Gustafsson Wallich were elected as new Board members.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.2 SEK | +4.52% | +4.18% | +116.00% |
05-27 | Sweden’s IRLAB Therapeutics Names New CEO | MT |
05-27 | IRLAB Therapeutics AB Announces CEO Changes, Effective from August 1, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+116.00% | 79.68M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- IRLAB A Stock
- News IRLAB Therapeutics AB
- IRLAB Therapeutics AB Approves Board Appointments